Moreover, pharmacological inhibition of SIRT1/2 interferes with the Wnt pathway by decreasing the expression of Dishevelled proteins, frizzled 7 receptor (FZD7) and beta-catenin in various cancer cells, which ultimately leads to inhibition of cell growth and cell migration [47,48]. The gene discussed is SIRT1; the disease is cancer.